Indeed unmutated IGHV status and 11q22 deletion were recognized as independent predictors of an unfavorable outcome [23, 24] while 17p13 deletion was aggregated with TP53 mutations in a category that received the highest risk score in the international prognostic index (IPI) of CLL [24]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.